IP Verse

Green Cross Corporation competitive analysis

Latest oppositions filed by Green Cross Corporation

Explore patent oppositions filed by Green Cross Corporation against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Mar 12, 2026
Patent NumberTitleApplicantOpposition Date
EP3626258
Methods And Compositions For Cns Delivery Of Iduronate-2-SulfataseSHIRE HUMAN GENETIC THERAPIESMay 3, 2022
EP3103469
Cns Delivery Of Therapeutic AgentsSHIRE HUMAN GENETIC THERAPIESSep 9, 2021

Latest PTAB cases involving Green Cross Corporation

Discover the latest PTAB cases involving Green Cross Corporation, highlighting their recent legal challenges and patent disputes.

Last updated on: Mar 13, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Green Cross Corporation

IPR2016-00258Nov 25, 2015GREEN CROSSSHIRE HUMAN GENETIC THERAPIESFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Green Cross Corporation with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Mar 12, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GREEN CROSS2 - 1 -
SHIRE HUMAN GENETIC THERAPIES314 - 1
TAKEDA PHARMACEUTICAL121 - 1